Chemcon Speciality Chemicals Ltd (CHEMCON) is currently trading at 194.10 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Chemcon Speciality Chemicals Limited manufactures specialty chemicals for pharmaceutical, agrochemical, aromatics, engineering, and oilfield applications, operating organic and inorganic chemical businesses from two Vadodara facilities. Its key products include HMDS, CMIC, bromobenzene, 2-Bromo, and inorganic bromides used in pharmaceutical intermediates and oilwell completion fluids. Q2 FY27 revenue increased 22% year-on-year to ₹65.4 crore, while EBITDA rose 61% to ₹11.0 crore and PAT grew 31% to ₹7.5 crore. The sharp operating improvement occurred despite lower chemical prices, weak inorganic-chemical offtake, crude volatility, geopolitical uncertainty, and reduced oil-drilling activity. The business mix is shifting decisively toward organic chemicals, which increased to 82% of Q2 FY27 revenue from 77% previously, while inorganic chemicals fell to 5% from 17%. Organic volumes were broadly stable, indicating that improved realizations and product mix, rather than volume expansion alone, supported current growth. Chemcon claims strong niche positions, including being India’s only HMDS manufacturer, the world’s third-largest HMDS manufacturer, the world’s largest CMIC manufacturer, and India’s only zinc-bromide manufacturer. The company also identifies itself as India’s largest calcium-bromide manufacturer, supporting differentiated positioning across pharmaceutical and oilfield chemical markets. The balance sheet remains relatively strong, with ₹477.8 crore of equity and only ₹27.3 crore of current borrowings at September 2026. Operating cash flow reached ₹43.1 crore in H1 FY27, while receivables declined to ₹42.1 crore from ₹63.5 crore at March 2026, although financing outflows and ongoing capital requirements remain relevant considerations.

Over the past 52 weeks, Chemcon Speciality Chemicals Ltd has traded between a low of ₹125.15 and a high of ₹247.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Chemcon Speciality Chemicals Ltd has a market capitalization of approximately 696.72. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Chemcon Speciality Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 23.27 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 696.72 Cr, Chemcon Speciality Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Chemcon Speciality Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Chemcon Speciality Chemicals Ltd is 23.27. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Standalone net sales were ₹66.49 crore in June 2026, up 24.23% from ₹53.52 crore in June 2025.